Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZVRA
#2801
Zevra Therapeutics, Inc. Common Stock
10.400
0
USD
+0.78%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.78%
Monthly Change
+5.37%
6 month change
-2.26%
Year Change
-2.26%
Previous Close
10.320
0
Open
10.400
0
Bid
Ask
Low
10.400
0
High
10.400
0
Volume
57
Markets
US Stock Market
Healthcare
ZVRA
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
54.12 M
54.68 M
56.14 M
56.3 M
58.71 M
—
Valuation ratios
Enterprise value
477.05 M
432.3 M
507.53 M
542.26 M
525.58 M
2.01 B
Price to earnings ratio
-3.66
-3.91
-38.29
20.91
6.64
-14.66
Price to sales ratio
16.34
28.57
14.31
9.47
4.82
57.18
Price to cash flow ratio
-5.54
-6.73
-12.21
-36.88
-321.07
-376.89
Price to book ratio
9.72
2.75
2.18
1.92
3.32
10.17
Enterprise value to EBITDA ratio
-7.14
-8.6
-16.93
-254.76
26.13
-254.17
Profitability ratios
Return on assets %
-0.2
-0.02
0.29
-0
0.04
0.31
Return on equity %
-0.9
-0.08
0.64
-0
0.08
0.64
Return on invested capital %
-106.69
-34.5
-385.46
17.92
47.89
-354.14
Gross margin %
75.24
85.49
52.17
95.25
95.55
328.46
Operating margin %
-128.01
-26.28
-274.48
15.9
27.3
-257.57
EBITDA margin %
-89.56
-3.69
12.82
23.36
33.74
66.22
Net margin %
-296.76
-15.19
288.66
-2.09
35.65
307.03
Liquidity ratios
Quick ratio
2.47
2.93
7.81
8.57
5.63
24.94
Current ratio
2.53
3.02
7.85
8.62
5.68
25.17
Inventory turnover
0.56
1.31
6.75
1
0.98
10.04
Asset turnover
0.07
0.12
0.12
0.1
0.12
0.46
Solvency ratios
Debt to assets ratio
0.33
0.35
0.24
0.23
0.22
1.03
Debt to equity ratio
1.5
1.46
0.52
0.46
0.4
2.84
Long term debt to total assets ratio
0.33
0.35
0.24
0.23
0.22
1.03
Long term debt to total equity ratio
1.5
1.46
0.52
0.46
0.4
2.84
Per share metrics
Operating cash flow per share
-0.35
0.07
-0.06
0.08
0.1
0.19
EBIT per share
-0.27
0.02
0.03
0.1
0.19
0.35
EBITDA per share
-0.23
0.01
0.06
0.11
0.2
0.38
Total debt per share
1.29
-0.54
1.08
1.1
1.08
2.72
Cash per share
1.5
-0.56
3.6
3.57
3.34
9.94
Net current asset value per share
1.86
-0.73
4.02
4.02
3.89
11.21
Tangible book value per share
-0.74
0.28
1.87
2.18
2.51
6.83
Working capital per share
1.12
-0.49
3.51
3.56
3.21
9.79
Book value per share
0.86
-0.37
2.08
2.38
2.7
6.8
News
BTIG initiates Zevra Therapeutics stock with buy on Miplyffa outlook
Micron and BioNTech among market cap stock movers on Tuesday
Micron and Palantir among market cap stock movers on Tuesday
ExxonMobil, Chevron edge lower premarket; Hewlett Packard Enterprise climbs
Guggenheim raises Zevra Therapeutics stock price target to $23
Earnings call transcript: Zevra Therapeutics Q4 2025 earnings beat forecasts
Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call Transcript
Zevra Therapeutics earnings beat by $0.14, revenue topped estimates
Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates
Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares